DSRV.io · Enforcement-informed quality intelligence
DSRVDSRV.io
Browse by regulation1 article · 1 moderate

21 CFR 7.40

Every DSRV article whose Regulatory Snapshot cites 21 CFR 7.40: the enforcement case behind it, the inspection exposure it created, and what the desk would do about it.

Inspection exposure across the set
In brief
What has FDA cited under 21 CFR 7.40?
1 DSRV article cite 21 CFR 7.40. Enforcement cases behind them: FDA warning letter closeout to Nephron SC, LLC, Case No. 634647, May 8, 2026, closing the October 11, 2022 warning letter with an explicit sustainability caveat; read alongside the FDA voluntary recall notice from JXK Enterprises, Inc., May 23, 2026, for undeclared sildenafil in a consumer chocolate product. Inspection exposure across them: 1 moderate.
What does DSRV recommend for 21 CFR 7.40?
From the newest article (What a Recall and a Closeout Letter Say About Quality Systems: Hidden Sildenafil, CAPA Sustainability, and Inspection Readiness): A closeout means the firm documented what it did, not that the system is fixed; the decisive controls are scheduled re-verification of corrections, CAPA ownership assigned beyond the original remediation lead, and a weekly recall-feed review that catches category signals before they reach the supply chain. DSRV is decision support, not legal advice; verify against the official source each article names.
  1. 8 min readModerate exposure

    What a Recall and a Closeout Letter Say About Quality Systems: Hidden Sildenafil, CAPA Sustainability, and Inspection Readiness

    Two FDA actions in May 2026 — a voluntary recall for undeclared sildenafil and a warning-letter closeout with an explicit sustainability caveat — point to the same quality lesson: finding the issue is only the first control.

    Case
    FDA warning letter closeout to Nephron SC, LLC, Case No. 634647, May 8, 2026, closing the October 11, 2022 warning letter with an explicit sustainability caveat; read alongside the FDA voluntary recall notice from JXK Enterprises, Inc., May 23, 2026, for undeclared sildenafil in a consumer chocolate product.
    DSRV take
    A closeout means the firm documented what it did, not that the system is fixed; the decisive controls are scheduled re-verification of corrections, CAPA ownership assigned beyond the original remediation lead, and a weekly recall-feed review that catches category signals before they reach the supply chain.
Address this risk

Pressure-test your evidence before an inspector reads it

Bring the document that has to hold up under 21 CFR 7.40. DSRV maps the evidence, names the gaps, and routes judgment calls to human review. Controlled intake, no public file upload.

Apply for the Stability Pilot Ask The Vault about 21 CFR 7.40

Regulatory intelligence and interpretation, not legal advice. Verify against the official FDA or ICH source each article names.